NOVARTIS ACCESS IN KENYA
In September 2015, MSH collaborated with Novartis and the Kenyan government to launch the pilot of Novartis Access—the first pharmaceutical industry program to focus on affordability and availability of medicines addressing chronic diseases. With Novartis Access in Kenya, MSH is working to ensure lifesaving medicines for cancer, diabetes, and heart and lung disease are delivered at affordable prices to the right place and at the right time to people in low-income communities. MSH facilitates this groundbreaking social business model by supporting inventory management and distribution channels to get affordable drugs to those affected and ensuring they understand how to use them. The five-year program will eventually be rolled out to 30 countries.